GSK PLC shares fall 5.42 percent amid broad market downturn

10 articles · Updated · MarketWatch · Apr 29

GSK PLC closed at £19.18 on Wednesday, with trading volume reaching 10.9 million, well above the 50-day average of 7.4 million.
The company's shares underperformed the FTSE 100 Index, which declined 1.16% to 10,213.11 during the same session.
GSK PLC now stands 15.95% below its 52-week high of £22.82, last reached on February 18th, reflecting ongoing market volatility.

With analysts calling it undervalued, is GSK stock a bargain hiding in plain sight?

Why did rival AstraZeneca soar while GSK stumbled in a turbulent market?

What 'quality concerns' led investors to dismiss GSK's impressive earnings beat?

Is GSK's promising drug pipeline enough to overcome its looming patent crisis?

As war and oil prices spook markets, can strong company earnings still matter?